2011 Labelling People Management 
The Checkup by Singlecare
NOVEMBER 15, 2024
Additionally, the FDA hasn’t listed any known interactions for the medications on the losartan or amlodipine labels. A 2011 study showed that the combination is more effective than amlodipine monotherapy, while one from 2023 demonstrated that it’s more effective than taking losartan alone.
The Thyroid Pharmacist
NOVEMBER 15, 2024
Ozempic is a GLP-1 agonist and is actually marketed as a diabetes drug, but many physicians are prescribing it for weight loss (off label-use). Ozempic’s label warns, “In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. Epub 2011 Dec 14. Eur J Endocrinol.
Expert insights. Personalized for you.
52 
Let's personalize your content